Cardiovascular Diseases Clinical Trial
Official title:
Adaptive Internet-based Stress Management Among Adults With a Cardiovascular Disease: A Pilot Sequential Multiple Assignment Randomized Trial (SMART) Design
Internet-based stress management programs adapted to patients' needs
Stress is inevitable, and it has many negative consequences on the health of everybody, but
particularly on the health of patients with a cardiovascular disease (CVD). The good news is
that patients with CVD can learn to better control their stress through stress management
programs. Most stress management programs are offered face-to-face by a trained health care
professional. Research has shown that these programs have a positive impact on the health of
patients with CVD, including reducing mortality and other risk factors that can make the
disease worse (e.g., reduces blood pressure). Because of these benefits, the recommendation
is to offer a stress management program to as many patients with CVD as possible. The problem
is that their delivery is challenging for most clinics (e.g., too costly to run, health care
professionals are not available). This means many good stress management programs never make
it to the patient. Patients also face barriers in accessing traditional stress management
programs such as stigma or need to travel. Therefore, new approaches are needed to allow
findings from research to actually have an impact on the public's health.
One of these approaches is to use the internet to deliver stress management programs. The
internet has now been used for about 10 years to deliver a range of programs to patients.
There are limitations to this approach as well. For instance, 40-60% of patients who will use
an internet-based program will not benefit from it. These patients need more support or
guidance to get the most out of their internet-based program. This is the problem addressed
using the proposed innovative trial design. Investigators aim to improve the number of
patients with CVD who improve after receiving a stress management program by changing the
type and level of support they receive over time. This type of innovative trial design is
more and more popular, but has never been used to enhance a stress management programs for
patients with CVD.
BACKGROUND: Stress has a negative impact on the experience of individuals with a
cardiovascular disease—both directly (e.g., physiologic effects of stress may worsen
cardiovascular disease) and indirectly (e.g., leads to higher perceived symptom severity).
Therefore, stress management has become an extensively researched form of psychological
therapy for these individuals, and is increasingly offered through the internet. Advantages
of internet-based interventions include being time efficient (e.g., cut travel time),
reducing waiting-lists, and increasing access for some sub-groups of the population (e.g.,
those living in rural and remote areas). Internet-based interventions also have the potential
to integrate effective features of face-to-face interventions (e.g., tailored feedback,
monitoring), but offer the scalability needed for public health interventions. However, up to
60% of individuals do not respond to these interventions, and for these individuals offering
different types of support or increasing the intensity of the support provided is necessary.
An innovative trial design to develop time-varying, adaptive interventions to maximize
clinical effectiveness is the Sequential multiple assignment randomized trials (SMARTs).
However, despite increasing popularity, SMARTs remain relatively new to intervention
researchers.
GOAL AND OBJECTIVES: The goal of this pilot Sequential Multiple Assignment Randomized Trial
(SMART) is to inform the planning of a subsequent larger SMART to evaluate an adaptive
internet-based stress management program that follows a stepped-care model for adults with a
cardiovascular disease. The primary objectives are to examine the (a) feasibility of the
SMART procedures and different combinations of the stress management program (recruitment,
retention, and questionnaire completion rates, reach, and fidelity) and (b) acceptability of
the combinations of the stress management program, including adapting the program for
non-responders and assessing adherence, satisfaction, and stress management strategies
learned. The secondary objective is to estimate the program's effect size to inform sample
size calculations for a full-scale SMART.
METHODOLOGY: 56 patients with a physician confirmed diagnosis of a cardiovascular disease
will be recruited through clinic referrals and community-based study advertisement. Inclusion
criteria are: (a) moderate stress (stress subscale score of 15 or more on Depression,
Anxiety, and Stress Scale), (b) at least 18 years of age, (c) not participated in a stress
management intervention in the past year, (e) regular access to a computer with internet and
e-mail capabilities, and (f) reports understanding English or French. Eligibility will be
confirmed mainly by self-report at the time of a screening interview. After completing their
consent form and baseline questionnaire (T0), participants will be randomized to either: (a)
a 6-week self-directed, web-based stress management program or (b) the same program plus
weekly lay coaching. At the end of 6 weeks, intervention response will be assessed (T1
questionnaire), and non-responders will include those who have a stress score that did not
improve (i.e., less than 50% decrease) or have a stress score above the cut-off point for
mild stress (primary tailoring variable). In both groups, non-responders will then be
randomized a second time to either (a) continue with their first stage program or (b)
professionally-led motivational interviewing for another 6 weeks. During this time,
responders will continue their first stage programs. The internet-based stress management
program is available through my Health CheckUp. All participants will then complete their
12-13 weeks follow-up questionnaire (T2) to examine changes in stress and quality of life
(primary outcomes), anxiety, depression, illness appraisal, self-efficacy, physical activity,
and coping (secondary outcomes). Acceptability will be assessed by the satisfaction measure
included in the follow-up questionnaire and further explored during an exit interview with
participants. Feasibility measures will focus on the characteristics of the participants
reached, protocol fidelity, percent of missing data, and recruitment and retention rates.
SIGNIFICANCE: The potential reach of internet-based interventions promises considerable
public health impact. However, to maximize impact, the most effective interventions need to
be developed and adapted to patients' evolving needs. This study will use the innovative
SMART design to evaluate an adaptive internet-based intervention for individuals with a
physical chronic illness.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|